D. M. Janzen Et Al. , "Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition In Vivo," MOLECULAR CANCER THERAPEUTICS , vol.12, no.12, pp.2917-2928, 2013
Janzen, D. M. Et Al. 2013. Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition In Vivo. MOLECULAR CANCER THERAPEUTICS , vol.12, no.12 , 2917-2928.
Janzen, D. M., Paik, D. Y., Rosales, M. A., Yep, B., Cheng, D., Witte, O. N., ... KAYADİBİ, H.(2013). Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition In Vivo. MOLECULAR CANCER THERAPEUTICS , vol.12, no.12, 2917-2928.
Janzen, Deanna Et Al. "Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition In Vivo," MOLECULAR CANCER THERAPEUTICS , vol.12, no.12, 2917-2928, 2013
Janzen, Deanna M. Et Al. "Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition In Vivo." MOLECULAR CANCER THERAPEUTICS , vol.12, no.12, pp.2917-2928, 2013
Janzen, D. M. Et Al. (2013) . "Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition In Vivo." MOLECULAR CANCER THERAPEUTICS , vol.12, no.12, pp.2917-2928.
@article{article, author={Deanna M. Janzen Et Al. }, title={Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition In Vivo}, journal={MOLECULAR CANCER THERAPEUTICS}, year=2013, pages={2917-2928} }